Clinical trial Recruiting at 1 site Interventional Ages 21 to 70

Hybrid HIIT-FES cycling program for people with spinal cord injury

Official title: The Effects of a Hybrid HIIT-FES Cycling Program on Individuals With Spinal Cord Injury to Improve Cardiovascular and Metabolic Health

Run by William Carey University · NCT07648173 · Data updated 2026-11-12

This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.

More Spinal Cord Injuries trials

Quick facts

Study typeInterventional
Ages21 Years to 70 Years
SexAll
Enrollment12 (estimated)
SponsorWilliam Carey University
Academic / other
Locations1 site (Hattiesburg, Mississippi)
StatusRecruiting
StartedMarch 3, 2026
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedJuly 2, 2026
Trial IDNCT07648173 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21-70 with chronic spinal cord injury (AIS A-C) from C4 to T12 who can perform voluntary arm cycling.

Probably not a fit

Individuals with uncontrolled cardiovascular disease, uncontrolled Type-2 diabetes, severe osteoporosis, or other conditions precluding leg and arm cycling may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates a hybrid exercise approach for adults with spinal cord injury, aiming to improve obesity and cardiometabolic risk factors. Participants perform an initial muscle-strengthening segment followed by Hybrid FES cycling, with additional active arm ROM and passive leg ROM as part of the protocol. The program targets engagement of large leg muscle groups via FES cycling alongside voluntary upper-body activity to potentially reduce fat mass and improve metabolic health. Eligible participants are adults aged 21-70 with chronic SCI (C4-T12, AIS A-C) and the ability to perform voluntary arm cycling. The study is led by William Carey University in Hattiesburg, Mississippi, and does not list a separate sponsor or collaborators beyond the lead site.

Why it matters

Potential benefit: If successful, participants could experience improved cardiometabolic health and body composition through a combined FES-assisted leg cycling and arm exercise program.

How similar studies have gone: Previous research suggests that combining FES cycling with arm exercise can improve metabolic health in SCI, but results vary by protocol and population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* men and women ages 21-70 years
* C4-T12 SCI American Spinal Injury Association Impairment Scale A, B, and C as per International Standards for Neurological Classification of SCI
* ≥1 years post-SCI
* Participants must be able to perform voluntary arm cycling.

Exclusion Criteria:

* pressure wounds on buttocks or feet
* unhealed bone fractures or history of fragility fractures
* uncontrolled cardiovascular disease
* uncontrolled Type-2 diabetes
* severe osteoporosis (T score below -4)
* uncontrolled autonomic dysreflexia
* orthopedic or other problems that preclude leg and arm cycling.

Where it's running

  • William Carey University
    Hattiesburg, Mississippi, United States
    Recruiting

Study contacts

  • Principal investigator: David R Dolbow, DPT, PhD — William Caery University
  • Study coordinator: David R Dolbow, DPT, PhD
  • Email: ddolbow@wmcarey.edu
  • Phone: 601-318-6274

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.